These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4074198)

  • 1. Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics.
    Laakso M; Voutilainen E; Pyörälä K; Sarlund H
    Arteriosclerosis; 1985; 5(6):653-8. PubMed ID: 4074198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics.
    Laakso M; Voutilainen E; Sarlund H; Aro A; Pyörälä K; Penttilä I
    Atherosclerosis; 1985 Sep; 56(3):271-81. PubMed ID: 3902037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.
    Laakso M; Lehto S; Penttilä I; Pyörälä K
    Circulation; 1993 Oct; 88(4 Pt 1):1421-30. PubMed ID: 8403288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects.
    Rönnemaa T; Laakso M; Pyörälä K; Kallio V; Puukka P
    Arterioscler Thromb; 1991; 11(1):80-90. PubMed ID: 1988007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation of plasma lipids and lipoproteins in families with and without coronary heart disease.
    Friedlander Y; Kark JD; Fainaru M; Gotsman M; Stein Y
    Atherosclerosis; 1985 Nov; 57(2-3):235-47. PubMed ID: 4084357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.
    Buring JE; O'Connor GT; Goldhaber SZ; Rosner B; Herbert PN; Blum CB; Breslow JL; Hennekens CH
    Circulation; 1992 Jan; 85(1):22-9. PubMed ID: 1728453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
    Laakso M; Pyörälä K
    Metabolism; 1990 Feb; 39(2):117-22. PubMed ID: 2299984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse relationship of serum HDL and HDL2 cholesterol to C-peptide level in middle-aged insulin-treated diabetics.
    Laakso M; Voutilainen E; Sarlund H; Aro A; Pyörälä K; Penttilä I
    Metabolism; 1985 Aug; 34(8):715-20. PubMed ID: 3894877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus.
    Laakso M; Pyörälä K; Sarlund H; Voutilainen E
    Arteriosclerosis; 1986; 6(6):679-84. PubMed ID: 2877651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort.
    Williams PT; Feldman DE
    Atherosclerosis; 2011 Jan; 214(1):196-202. PubMed ID: 21109246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus.
    Winocour PH; Durrington PN; Bhatnagar D; Mbewu AD; Ishola M; Mackness M; Arrol S
    Diabetes Res Clin Pract; 1992 Dec; 18(3):173-84. PubMed ID: 1289018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The nature of changes in lipid metabolism in patients with diabetes mellitus associated with ischemic heart disease].
    Bakhshalieva SB; Aliev TA; Rakhmann SA
    Kardiologiia; 1990 Sep; 30(9):61-4. PubMed ID: 2273741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid parameters in newly detected type II diabetic patients and relations to coronary heart disease].
    Häntzschel U; Wurlitzer M; Kuhfahl E; Dempe A
    Z Gesamte Inn Med; 1987 Oct; 42(20):571-5. PubMed ID: 3433844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease.
    Kesavulu MM; Rao BK; Giri R; Vijaya J; Subramanyam G; Apparao C
    Diabetes Res Clin Pract; 2001 Jul; 53(1):33-9. PubMed ID: 11378211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
    Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipids and lipoproteins in symptomatic coronary heart disease. Distribution, intercorrelations, and significance for risk classification in 6,700 men and 1,500 women. The Bezafibrate Infarction Prevention (BIP) Study Group, Israel.
    Circulation; 1992 Sep; 86(3):839-48. PubMed ID: 1516196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on serum triglyceride and lipoproteins cholesterol in coronary heart disease patients.
    Awan ZA; Baseer A
    J Pak Med Assoc; 1995 Oct; 45(10):263-6. PubMed ID: 8714621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of obesity and hypertriglyceridaemia on the low HDL2-cholesterol level and on its relationship with prevalence of atherosclerosis in type 2 diabetes.
    Verges B; Brun JM; Vaillant G; Quantin C; Brunet-Lecomte P; Farnier M; Gambert P
    Diabete Metab; 1992; 18(4):289-97. PubMed ID: 1459317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects.
    Ballantyne FC; Clark RS; Simpson HS; Ballantyne D
    Metabolism; 1982 May; 31(5):433-7. PubMed ID: 6952064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoproteins and apolipoproteins in young male survivors of myocardial infarction.
    Al-Muhtaseb N; Hayat N; Al-Khafaji M
    Atherosclerosis; 1989 Jun; 77(2-3):131-8. PubMed ID: 2751745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.